[go: up one dir, main page]

DE69920683D1 - Selektiv auf den cb2-rezeptor wirkende cannabinoide - Google Patents

Selektiv auf den cb2-rezeptor wirkende cannabinoide

Info

Publication number
DE69920683D1
DE69920683D1 DE69920683T DE69920683T DE69920683D1 DE 69920683 D1 DE69920683 D1 DE 69920683D1 DE 69920683 T DE69920683 T DE 69920683T DE 69920683 T DE69920683 T DE 69920683T DE 69920683 D1 DE69920683 D1 DE 69920683D1
Authority
DE
Germany
Prior art keywords
receptor
selective
cannabinoids
cannabinoid
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69920683T
Other languages
English (en)
Other versions
DE69920683T2 (de
Inventor
Alexandros Makriyannis
Atmaram Khanolkar
Dai Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Connecticut
Original Assignee
University of Connecticut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Connecticut filed Critical University of Connecticut
Publication of DE69920683D1 publication Critical patent/DE69920683D1/de
Application granted granted Critical
Publication of DE69920683T2 publication Critical patent/DE69920683T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69920683T 1998-05-04 1999-05-04 Selektiv auf den CB2-Rezeptor wirkende Cannabinoide Expired - Fee Related DE69920683T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8412998P 1998-05-04 1998-05-04
US84129P 1998-05-04
PCT/US1999/009806 WO1999057107A2 (en) 1998-05-04 1999-05-04 Cannabinoids selective for the cb2 receptor

Publications (2)

Publication Number Publication Date
DE69920683D1 true DE69920683D1 (de) 2004-11-04
DE69920683T2 DE69920683T2 (de) 2005-04-07

Family

ID=22183058

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920683T Expired - Fee Related DE69920683T2 (de) 1998-05-04 1999-05-04 Selektiv auf den CB2-Rezeptor wirkende Cannabinoide

Country Status (7)

Country Link
US (1) US6166066A (de)
EP (1) EP1076653B1 (de)
AT (1) ATE277921T1 (de)
CA (1) CA2340444A1 (de)
DE (1) DE69920683T2 (de)
ES (1) ES2224658T3 (de)
WO (1) WO1999057107A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE277921T1 (de) * 1998-05-04 2004-10-15 Univ Connecticut Selektiv auf den cb2-rezeptor wirkende cannabinoide
US20010009965A1 (en) * 1998-05-04 2001-07-26 Alexandros Makriyannis Novel analgesic and immunomodulatory cannabinoids
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US20070179135A1 (en) * 2006-01-05 2007-08-02 Travis Craig R Cannabinoid derivatives
AU778159B2 (en) 1999-10-18 2004-11-18 University Of Connecticut, The Peripheral cannabinoid receptor (CB2) selective ligands
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US6943266B1 (en) * 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US7119108B1 (en) * 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
KR20030008153A (ko) * 2000-06-22 2003-01-24 파모스 코포레이션 신규 비-향정신성 카나비노이드
US7235584B2 (en) * 2000-06-22 2007-06-26 Pharmos Corporation Non-psychotropic cannabinoids
EP1361876A4 (de) 2001-01-26 2004-03-31 Univ Connecticut Neue cannabimimetische liganden
WO2002060447A1 (en) 2001-01-29 2002-08-08 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles
AU2002320430A1 (en) * 2001-07-13 2003-01-29 University Of Connecticut Novel bicyclic and tricyclic cannabinoids
US7666867B2 (en) * 2001-10-26 2010-02-23 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
CA2468794A1 (en) * 2001-12-07 2003-06-19 Virginia Commonwealth University Treatment of neoplasia
WO2003075917A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
WO2004103410A1 (en) 2002-06-06 2004-12-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods compositions and articles of manufacture for modulating bone growth
US7183313B2 (en) 2002-08-23 2007-02-27 University Of Connecticut Keto cannabinoids with therapeutic indications
IL160420A0 (en) * 2004-02-16 2004-07-25 Yissum Res Dev Co Treating or preventing diabetes with cannabidiol
WO2005123053A2 (en) * 2004-06-22 2005-12-29 Pharmos Limited Use of cb2 receptors agonists for the treatment of huntington’s disease
US7781650B2 (en) * 2007-04-30 2010-08-24 Monsanto Technology Llc Plants and seeds of corn variety CV202909
US9575319B2 (en) 2014-03-10 2017-02-21 Ion Virtual Technology Corporation Method and system for reducing motion blur when experiencing virtual or augmented reality environments
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
JP2020524679A (ja) 2017-06-20 2020-08-20 イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー. カンナビジオール酸エステル組成物およびその使用
EP3745884A1 (de) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hanfpulver
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
MX2021010875A (es) 2019-03-12 2021-12-10 Epm Ip Inc Composiciones de éster de ácido cannabinoide y sus usos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915996A (en) * 1972-10-16 1975-10-28 Abbott Lab Process for making benzopyrans
US3886184A (en) * 1973-08-03 1975-05-27 Lilly Co Eli Aminodibenzo(b,d)pyrans
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5440052A (en) * 1993-08-06 1995-08-08 University Of Connecticut Compositions useful as a cannabinoid receptor probe
FR2735774B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant
US5688825A (en) * 1996-05-31 1997-11-18 University Of Connecticut Anandamide amidase inhibitors as analgesic agents
US20010009965A1 (en) * 1998-05-04 2001-07-26 Alexandros Makriyannis Novel analgesic and immunomodulatory cannabinoids
ATE277921T1 (de) * 1998-05-04 2004-10-15 Univ Connecticut Selektiv auf den cb2-rezeptor wirkende cannabinoide

Also Published As

Publication number Publication date
WO1999057107A3 (en) 2000-02-03
WO1999057107A2 (en) 1999-11-11
EP1076653B1 (de) 2004-09-29
ATE277921T1 (de) 2004-10-15
EP1076653A2 (de) 2001-02-21
US6166066A (en) 2000-12-26
ES2224658T3 (es) 2005-03-01
DE69920683T2 (de) 2005-04-07
CA2340444A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
DE69920683D1 (de) Selektiv auf den cb2-rezeptor wirkende cannabinoide
DE69605430D1 (de) Chinolin-2-on derivate als serotonin antagonisten
ID26697A (id) Pemurnian neurotrofin
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
ATE175198T1 (de) N-acylierte trizyklische azaheteroringe verwendbar als vasopressin-antagonisten
TR200000782T2 (tr) Resorsinol türevleri.
ATE254456T1 (de) Cannabinoid-rezeptor-antagonisten
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
NO964236L (no) Anvendelse av serotonin-antagonister (5HT3) for behandling av fibromyalgi
AR002459A1 (es) Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
DE60012040D1 (de) Trizyklische 1-benzylpyrazol-3-carbonsäurederivate als cannabinoidrezeptorantagonisten
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
DZ1468A1 (fr) Composés nouveaux.
ATE289810T1 (de) Ecteinascidinderivate
ES8505539A1 (es) Procedimiento para la obtencion de derivados de alcohol bencilico con propiedades sebosupresoras
ES2171911T3 (es) Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos.
EA199700242A1 (ru) Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нтрецептора
DK0983275T3 (da) Nye triptolidderivater, der er nyttige til behandling af autoimmune sygdomme
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
DE69707098D1 (de) Substituierte tetralylmethylenoxindol-analoga als tyrosinkinase-inhibitoren
TR199801612T2 (xx) Benzotiofen, benzotiofen i�eren form�ller ve y�ntemler.
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
AR012249A1 (es) Compuestos de amonio cuaternario, procedimiento para su preparacion, composicion farmaceutica que los contiene, y su uso para la preparacion de medicamentos
DK0946538T3 (da) Indan- eller dihydroindole derivater
BR9101438A (pt) Processo para preparacao de resina,bem como dispersao aquosa

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee